These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27581247)

  • 21. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall asthma control: the relationship between current control and future risk.
    Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
    J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
    van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
    J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
    Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease burden and treatment adherence among children and adolescent patients with asthma.
    Averell CM; Laliberté F; Germain G; Slade DJ; Duh MS; Spahn J
    J Asthma; 2022 Aug; 59(8):1687-1696. PubMed ID: 34346263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of asthma control by inhaled corticosteroids in general practice in Thailand.
    Boonsawat W; Boonsawat W; Thinkhamrop B
    Asian Pac J Allergy Immunol; 2015 Mar; 33(1):21-5. PubMed ID: 25840630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].
    Plaza V; Bellido-Casado J; Rodrigo GJ; Solarte I; Rodríguez-Trigo G; Sepúlveda R; Neffen H; Perpiñá M
    Arch Bronconeumol; 2009 Nov; 45(11):545-9. PubMed ID: 19651467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Aalbers R; Vogelmeier C; Kuna P
    Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of asthma mortality with inhaled long acting beta-agonists.
    Wijesinghe M; Perrin K; Harwood M; Weatherall M; Beasley R
    Postgrad Med J; 2008 Sep; 84(995):467-72. PubMed ID: 18940948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis.
    Jaeschke R; O'Byrne PM; Mejza F; Nair P; Lesniak W; Brozek J; Thabane L; Cheng J; Schünemann HJ; Sears MR; Guyatt G
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1009-16. PubMed ID: 18776152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.